KR101308767B1 - Preparation method of Pemetrexed diethyl ester with high purity and the preparation method of pemetrexed disodium salt comprising the thereof - Google Patents

Preparation method of Pemetrexed diethyl ester with high purity and the preparation method of pemetrexed disodium salt comprising the thereof Download PDF

Info

Publication number
KR101308767B1
KR101308767B1 KR1020110006082A KR20110006082A KR101308767B1 KR 101308767 B1 KR101308767 B1 KR 101308767B1 KR 1020110006082 A KR1020110006082 A KR 1020110006082A KR 20110006082 A KR20110006082 A KR 20110006082A KR 101308767 B1 KR101308767 B1 KR 101308767B1
Authority
KR
South Korea
Prior art keywords
pemetrexed
diethyl ester
purity
high purity
preparing
Prior art date
Application number
KR1020110006082A
Other languages
Korean (ko)
Other versions
KR20130027597A (en
Inventor
임근조
장순기
김재헌
Original Assignee
에스티팜 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스티팜 주식회사 filed Critical 에스티팜 주식회사
Priority to KR1020110006082A priority Critical patent/KR101308767B1/en
Publication of KR20130027597A publication Critical patent/KR20130027597A/en
Application granted granted Critical
Publication of KR101308767B1 publication Critical patent/KR101308767B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

본 발명은 1) 저순도 페메트렉세드 디에틸 에스테르를 디메틸포름아미드, 디메틸설폭시드, 디메틸아세트아미드 및 N-메틸피롤리다논 중에서 선택된 1종 용매와 C1-4의 알코올 중에서 선택된 1종의 공용매와의 혼합용매 중에 용해시켜 용액을 제조하는 단계; 2) 제1단계에서 제조된 용액에 반용매로 C3-C6 케톤, C3-C6 에스테르 및 아세토니트릴 중에서 선택된 1종을 첨가하여 결정을 석출시키는 단계; 및 3) 제2단계에서 제조된 결정을 여과, 세척, 건조시켜 순도가 98.5% 이상인 하기 화학식 1로 표시되는 고순도 페메트렉세드 디에틸 에스테르 제조방법을 제공한다. 또한, 본 발명은 본 발명의 고 순도 페메트렉세드 디에틸 에스테르의 제조방법을 포함하는 페메트렉세드 이나트륨염의 제조방법을 제공한다. The present invention relates to 1) a low-purity pemetrexed diethyl ester comprising one solvent selected from dimethylformamide, dimethyl sulfoxide, dimethylacetamide and N-methylpyrrolidanone and one alcohol selected from C1-4 alcohols. Dissolving in a mixed solvent with to form a solution; 2) precipitating crystals by adding one selected from C3-C6 ketone, C3-C6 ester and acetonitrile as antisolvent to the solution prepared in the first step; And 3) filtering, washing and drying the crystals prepared in the second step to provide a high purity pemetrexed diethyl ester represented by Chemical Formula 1 having a purity of 98.5% or more. The present invention also provides a process for preparing pemetrexed disodium salt comprising the process for preparing the high purity pemetrexed diethyl ester of the present invention.

Description

고 순도 페메트렉세드 디에틸 에스테르의 제조방법 및 이 방법을 포함하는 페메트렉세드 이나트륨염의 제조방법{Preparation method of Pemetrexed diethyl ester with high purity and the preparation method of pemetrexed disodium salt comprising the thereof}Preparation method of Pemetrexed diethyl ester with high purity and the preparation method of pemetrexed disodium salt comprising the

본 발명은 고순도 페메트렉세드 디에틸 에스테르의 제조방법 및 페메트렉세드 이나트륨염 제조방법에 관한 것이다.The present invention relates to a process for the preparation of high purity pemetrexed diethyl ester and to a process for the preparation of pemetrexed disodium salt.

페메트렉세드(Pemetrexed)는 N-(4-[2-(2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸]벤조일)-L-글루탐산{N-(4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrroro[2,3-d]pyrimidin-5-yl)ethyl]benzoyl)-L-glutamic acid}으로서 하기와 같은 화학식 I을 가지고 항엽산 활성을 나타내며, 일라이 릴리(Eli Lilly and Company)사에 의해 알림타(Alimta)��라는 상품명으로 페메트렉세드 이나트륨염 7수화물을 유효성분으로 하여 정맥 투여용 무균 동결 건조 분말로 폐암 및 흉막 중피종을 치료제로 판매되고 있다. Pemetrexed is N- (4- [2- (2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3- d ] pyrimidin-5-yl) ethyl ] Benzoyl) -L-glutamic acid {N- (4- [2- (2-amino-4,7-dihydro-4-oxo-1H-pyrroro [2,3- d ] pyrimidin-5-yl) ethyl] benzoyl ) -L-glutamic acid} has the following formula (I) and exhibits antifolate activity, Eli Lilly and It is a sterile lyophilized powder for intravenous administration with pemetrexed disodium salt heptahydrate under the trade name Alimta �� under the trade name of Alimta .

[화학식I]Formula I

Figure 112011004947099-pat00001
Figure 112011004947099-pat00001

페메트렉세드 이나트륨염은 대한민국 등록특허공보 제0162654호에 기재된 바와 같이, 하기 [반응식 1]과 같이 제조될 수 있다. Pemetrexed disodium salt may be prepared as shown in [Scheme 1], as described in Korean Patent Publication No. 0162654.

[반응식 1][Reaction Scheme 1]

Figure 112011004947099-pat00002
Figure 112011004947099-pat00002

위 [반응식 1]과 같이, 페메트렉세드 이나트륨염(2)은 페메트렉세드 디에틸 에스테르(1)을 염기 존재하에 가수분해시켜, 페메트렉세드(5)를 제조한 후 수산화나트륨과 반응시켜 제조된다. As shown in [Scheme 1], pemetrexed disodium salt (2) hydrolyzes pemetrexed diethyl ester (1) in the presence of a base to prepare pemetrexed (5) and then react with sodium hydroxide. Are manufactured.

이로 인해, 페메트렉세드 디에틸 에스테르의 순도가 높다면, 이후 반응에서는 최종생성물인 페메트렉세드 이나트륨의 순도를 높이기 위한 별도의 제조공정을 불필요하게 된다. For this reason, if the purity of the pemetrexed diethyl ester is high, there is no need for a separate manufacturing process for increasing the purity of the final product of pemetrexed disodium in the subsequent reaction.

따라서, 페메트렉세드 디에틸 에스테르의 고순도 고수율로 제조하는 방법을 계발하는 것이 중요하다. Therefore, it is important to develop a method for producing high purity and high yield of pemetrexed diethyl ester.

이에 따라, 본 발명의 목적은 고 순도의 피메트렉세드 디에틸 에스테르를 제조하는 방법을 제공하여, 최종 생성물인 피메트렉세드 이나트륨 염의 최종단계에서 별도로 요구되거나 복잡한 정제 공정을 회피하게 하는 것이다.Accordingly, it is an object of the present invention to provide a process for the preparation of high purity fimetrexed diethyl ester to avoid separately required or complicated purification processes in the final stage of the final product, pimetrexide disodium salt.

본 발명은 하기의 단계를 포함하는 하기 [화학식 1]의 고순도 페메트렉세드 디에틸 에스테르의 제조 방법을 제공한다:The present invention provides a process for preparing a high purity pemetrexed diethyl ester of the following Chemical Formula 1, comprising the following steps:

1) 저 순도 페메트렉세드 디에틸 에스테르를 디메틸포름아미드, 디메틸설폭시드, 디메틸아세트아마이드 및 N-메틸피롤리디논 중에서 선택된 1종 용매와 C1-4의 알코올 중에서 선택된 1종의 공용매와의 혼합용매 중에 용해시켜 용액을 제조하는 단계,1) Mixing low purity pemetrexed diethyl ester with one solvent selected from dimethylformamide, dimethyl sulfoxide, dimethylacetamide and N-methylpyrrolidinone and one cosolvent selected from alcohols of C1-4 Dissolving in a solvent to prepare a solution,

2)제1단계에서 제조된 용액에 반용매로 C3-C6 케톤, C3-C6 에스테르 및 아세토니트릴 중에서 선택된 1종을 첨가하여 결정을 석출시키는 단계 및, 2) precipitating crystals by adding one selected from C3-C6 ketone, C3-C6 ester and acetonitrile as an antisolvent to the solution prepared in the first step;

3)제2단계에서 제조된 결정을 여과, 세척, 건조시켜 순도가 98.5% 이상인 하기 화학식 1로 표시되는 고순도 페메트렉세드 디에틸 에스테르 제조방법: 3) a method of preparing high purity pemetrexed diethyl ester represented by the following Chemical Formula 1 having a purity of 98.5% or more by filtration, washing and drying the crystals prepared in the second step:

[화학식 1][Formula 1]

Figure 112011004947099-pat00003
Figure 112011004947099-pat00003

본 발명의 출발물질인 페메트렉세드 디에틸 에스테르는 상업적으로 판매되는 것을 이용할 수도 있으며, 한국 공개특허공보 제2008-0050594호에 기재된 바와 같이 공지된 방법으로 제조될 수 있다. 예를 들어, 4-(2-[2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸] 벤조산과 유기용매를 혼합한 후, N-메틸모르폴린을 첨가하고 0~5℃로 냉각시키고, 2-클로로-4,6-디메톡시-1,3,5-트리아진을 첨가하여 1시간 동안 교반시켰다. 이에 L-글루탐산 디에틸 에스테르 염산염을 넣고 실온에서 반응시킨 후, TLC 등으로 반응 완결을 확인하고, 반응혼합물에 물(186 ml) 및 유기용매를 첨가하여 층분리한 후, 유기층을 무수 에탄올 등으로 대체하고 승온시키고, p-톨루엔 설폰산을 첨가하여 페메트렉세드 디에틸 에스테르 p-톨루엔 설폰산염을 생성시켰다. 이를, 물을 포함한 혼합 유기용매에 탄산수소나트륨등으로 반응용액의 pH를 pH 8.0 내지 9.0로 조절한 후 페메트렉세드 디에틸 에스테르를 제조할 수 있다. The pemetrexed diethyl ester of the starting material of the present invention may be commercially available, and may be prepared by a known method as described in Korean Patent Laid-Open No. 2008-0050594. For example, 4- (2- [2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoic acid and an organic solvent After mixing, N-methylmorpholine was added, cooled to 0-5 [deg.] C., 2-chloro-4,6-dimethoxy-1,3,5-triazine was added and stirred for 1 hour. After adding L-glutamic acid diethyl ester hydrochloride and reacting at room temperature, the reaction was confirmed by TLC and the like, and water (186 ml) and an organic solvent were added to the reaction mixture to separate the layers, and the organic layer was dried with anhydrous ethanol or the like. Replaced and warmed up, and p-toluene sulfonic acid was added to produce pemetrexed diethyl ester p-toluene sulfonate. This, after adjusting the pH of the reaction solution to pH 8.0 to 9.0 in a mixed organic solvent containing water, such as sodium hydrogen carbonate can be prepared pemetrexed diethyl ester.

본 발명에서, 저순도는 95%이하의 순도를 의미하며, 바람직하게는 92%이하의 순도를 의미하며, 고순도는 98.5% 이상의 순도를 의미하며, 바람직하게는 99.0%이상의 순도를 의미한다. In the present invention, low purity means 95% or less purity, preferably 92% or less purity, high purity means 98.5% or more, preferably 99.0% or more.

본 발명에서, C1-4알코올은 메탄올, 에탄올, n-프로판올, 이소프로판올, n-부탄올, 이소부탄올 또는 tert-부탄올을 의미한다.In the present invention, C1-4 alcohol means methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol or tert-butanol.

본 발명에서, 1단계의 혼합용매는 디메틸포름아미드 또는 디메틸설폭시드 중 1종과 공용매로 에탄올의 혼합용매인 것이 바람직하다. In the present invention, the mixed solvent of one step is preferably a mixed solvent of ethanol as one of dimethylformamide or dimethyl sulfoxide and a cosolvent.

본 발명에서, 디메틸포름아미드, 디메틸아세트 아마이드, 디메틸설폭사이드 및 N-메틸 피롤리디논 중에서 선택된 1종 용매와 공용매의 혼합비는 다양하게 변할 수 있으나, 1: 2 내지 6 부피비인 것이 바람직하며, 바람직하게는 3:10 부피비인 것이 바람직하다.In the present invention, the mixing ratio of one solvent selected from dimethylformamide, dimethylacetamide, dimethyl sulfoxide, and N-methyl pyrrolidinone and the cosolvent may vary, but is preferably 1: 2 to 6 by volume, Preferably it is 3:10 volume ratio.

본 발명의 1단계의 혼합용매는 디메틸포름아미드 또는 디메틸설폭시드 중 1종과 에탄올의 혼합비가 3:10 부피비인 것이 보다 바람직하다. As for the mixed solvent of one step of this invention, it is more preferable that the mixing ratio of 1 type and ethanol of dimethylformamide or dimethyl sulfoxide is 3:10 volume ratio.

본 발명의 제1단계는 실온 내지 가온된 상태에서 수행될 수 있으며, 가온할 경우 40 내지 70℃가 바람직하며, 약 50℃가 보다 바람직하다. The first step of the present invention may be carried out at room temperature to a warmed state, preferably 40 to 70 ° C, more preferably about 50 ° C when warmed.

본 발명에서, 제2단계의 반용매는 아세톤인 것이 바람직하며, 반용매와 제1단계의 공용매의 혼합비는 1: 1 내지 3부피비 일 수 있으며, 3: 5 부피비인 것이 바람직하다.In the present invention, the anti-solvent of the second stage is preferably acetone, and the mixing ratio of the anti-solvent and the co-solvent of the first stage may be 1: 1 to 3 by volume, and preferably 3: 5 by volume.

본 발명에서, 반용매는 반응용액에 천천히 dropwise 하거나, 한꺼번에 투입할 수 있다. dropwise하는 것이 보다 바람직하다. In the present invention, the anti-solvent may be slowly dropwise to the reaction solution, or added at once. It is more preferable to dropwise.

본 발명의 제2단계는 실온 내지 가온된 상태에서 수행될 수 있으며, 반용매 첨가시의 온도는 가온된 상태가 바람직하나, 이후 반응은 실온에서 이루어지는 것이 바람직하다.The second step of the present invention can be carried out at room temperature to a warmed state, the temperature at the time of addition of the antisolvent is preferably a warmed state, the reaction is preferably carried out at room temperature.

본 발명에서, 제3단계의 세척은 C1-4인 알코올이 바람직하며, 이소프로판올이 더욱 바람직하다. In the present invention, the third step of washing is preferably an alcohol of C1-4, more preferably isopropanol.

본 발명의 3단계는 0 내지 실온에서 수행되는 것이 바람직하다.Preferably, step 3 of the present invention is carried out at 0 to room temperature.

본 발명에서 실온은 15 내지 30℃를 의미한다.In the present invention, room temperature means 15 to 30 ℃.

또한 본 발명의 3단계에서, 여과는 통상적으로 유기실험에서 사용되는 진공여과, filter 여과 등을 의미한다. 또한, 세척 및 건조는 유기실험에서 고체결정을 얻은 후 통상적으로 수행되는 세척, 건조를 의미한다. In addition, in the third step of the present invention, filtration means vacuum filtration, filter filtration, etc. that are commonly used in organic experiments. In addition, washing and drying means washing and drying which are usually performed after obtaining a solid crystal in an organic experiment.

또한, 본 발명은 본 발명의 고순도의 페메트렉세드 디에틸 에스테르 제조방법을 포함한 페메트렉세드 이나트륨염을 제조하는 방법을 제공한다. The present invention also provides a process for preparing the pemetrexed disodium salt, including the high-purity pemetrexed diethyl ester process of the present invention.

본 발명의 페메트렉세드 이나트륨염 제조방법은 하기의 단계를 포함한다: The process for preparing pemetrexed disodium salt of the present invention comprises the following steps:

1) 본 발명의 고순도 페메트렉세드 디에틸 에스테르 제조방법으로 고순도 페메트렉세드 디에틸에스테르를 제조하는 단계;1) preparing a high purity pemetrexed diethyl ester by the method for preparing high purity pemetrexed diethyl ester of the present invention;

2) 제1단계에서 제조된 페메트렉세드 디에틸 에스테르와 염기를 반응시킨 후 용액에 산을 첨가하여 반응용액의 pH를 2.5 내지 4.0으로 조정하여 페메트렉세드를 제조하는 단계; 및2) preparing pemetrexed by reacting the pemetrexed diethyl ester prepared in the first step with a base, and then adding an acid to the solution to adjust the pH of the reaction solution to 2.5 to 4.0; And

3) 제2단계에서 제조한 페메트렉세드와 수산화나트륨 또는 탄산나트륨과 반응시키고, 산을 첨가하여 반응용액의 pH를 7.5 내지 8.5로 조정하여 페메트렉세드 이나트륨염을 제조하는 방법. 3) A method of preparing pemetrexed disodium salt by reacting the pemetrexed prepared in the second step with sodium hydroxide or sodium carbonate and adding an acid to adjust the pH of the reaction solution to 7.5 to 8.5.

본 발명의 페메트렉세드 이나트륨염 제조방법에서, 제2단계의 염기는 에스테르기의 가수분해 반응에 사용되는 통상의 염기를 의미하며, 예를 들어, NaOCH3, NaOCH2CH3, KOCH3, KOCH2CH3, LiOH, NaOH, KOH, RbOH, CsOH, Ca(OH)2, SrOH, Ba(OH)2 등이 있다.In the process for preparing pemetrexed disodium salt of the present invention, the base of the second step means a conventional base used for the hydrolysis reaction of the ester group, for example, NaOCH 3 , NaOCH 2 CH 3 , KOCH 3 , KOCH 2 CH 3 , LiOH, NaOH, KOH, RbOH, CsOH, Ca (OH) 2 , SrOH, Ba (OH) 2 and the like.

본 발명의 페메트렉세드 이나트륨염 제조방법에서, 제2단계의 반응용매는 물, C1-4의 알코올, 또는 물과 C1-4의 알코올 혼합용매가 바람직하며, 반응온도는 실온이 바람직하나, 산 첨가시에는 약 50 내지 70℃로 가온할 수 있다. In the process for preparing pemetrexed disodium salt of the present invention, the reaction solvent of the second step is preferably water, an alcohol of C1-4, or an alcohol mixed solvent of water and C1-4, and the reaction temperature is preferably room temperature, When the acid is added, it can be heated to about 50 to 70 ℃.

본 발명의 페메트렉세드 이나트륨염 제조방법에서, 제2단계 또는 제3단계의 산은 염산, 황산, 질산 중에서 선택된 것이 바람직하며, 염산이 보다 바람직하다.In the method for producing pemetrexed disodium salt of the present invention, the acid of the second or third step is preferably selected from hydrochloric acid, sulfuric acid and nitric acid, more preferably hydrochloric acid.

본 발명의 페메트렉세드 이나트륨염 제조방법에서, 제3단계의 반응 후 유기 실험에서 통상적으로 행해지는 건조를 추가로 행할 수 있다. In the method for producing pemetrexed disodium salt of the present invention, drying after the reaction of the third step, which is usually performed in an organic experiment, can be further performed.

본 발명의 방법은 페메트렉세드 디에틸 에스테르 및 페메트렉세드 이나트륨염을 고순도 고수율로 제공하는 효과가 있다.The method of the present invention has the effect of providing high purity and high yield of pemetrexed diethyl ester and pemetrexed disodium salt.

이하, 실시예를 통하여 본 발명을 상세히 설명하기는 하나, 다음의 실시예는 본 발명을 설명하기 위한 것일 뿐 본 발명의 범위를 제한하는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to the following examples, but the following examples are only intended to illustrate the present invention and do not limit the scope of the present invention.

하기 실시예에서 제조한 페메트렉세드 디에틸 에스테르 및 페메트렉세드 이나트륨 염의 순도를 모니터링 하기 위한 HPLC 방법은 다음과 같다. The HPLC method for monitoring the purity of the pemetrexed diethyl ester and pemetrexed disodium salts prepared in the following examples is as follows.

1) 페메트렉세드 디에틸 에스테르의 순도를 모니터링하기 위한 HPLC 방법:1) HPLC method for monitoring the purity of pemetrexed diethyl ester:

Figure 112011004947099-pat00004
Figure 112011004947099-pat00004

2) 페메트렉세드 이나트륨 염의 순도를 모니터링하기 위한 HPLC 방법:2) HPLC method for monitoring the purity of pemetrexed disodium salt:

Figure 112011004947099-pat00005
Figure 112011004947099-pat00005

<< 제조예Manufacturing example > 저 순도의 N-(4-[2-(2-아미노-4,7-> Low purity N- (4- [2- (2-amino-4,7- 디히드로Dihydro -4-옥소-1H--4-oxo-1H- 피롤로[2,3-d]피리미딘Pyrrolo [2,3-d] pyrimidine -5-일)에틸]-5-yl) ethyl] 벤조일Benzoyl )-L-글루탐산 ) -L-glutamic acid 디에틸Diethyl 에스테르( ester( 페메트렉세드Pemetrexed 디에틸Diethyl 에스테르) 제조 Ester) manufacturer

플라스크에 4-(2-[2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸] 벤조산 (10.0 g)과 디메틸포름아미드(70 ml)를 넣고 20분 동안 교반한 후 N-메틸모르폴린(10.3 g)을 첨가하였다. 혼합물을 5℃로 냉각시키고, 2-클로로-4,6-디메톡시-1,3,5-트리아진 (7.53 g)을 첨가하였다. 반응물을 5℃에서 1시간 동안 교반 한 후 L-글루탐산 디에틸 에스테르 염산염(10.3 g)을 넣고 25℃로 승온시켰다. 약 1시간 후 TLC에 의해 반응의 완결을 확인하고, 반응혼합물에 물(186 ml)와 디클로로메탄(186 ml)를 첨가하고 15 분 동안 교반하고 정치하였다. 층분리하고 유기층을 감압 농축한 다음 무수 에탄올(340 ml)로 대체하였다. 반응용액을 75℃로 가열하고, 무수 에탄올(290 ml)에 용해된 p-톨루엔 설폰산(16.8 g)을 반응혼합물에 1시간 동안 서서히 적가하였다. 생성된 슬러리를 1시간 동안 환류시킨 후 25℃로 냉각시키고 여과하였다. 무수 에탄올(134 ml)로 세척하여 페메트렉세드 디에틸 에스테르 p-톨루엔 설폰산염을 얻었다. 이렇게 얻어진 고체(10.0 g)를 에탄올(100 ml), 디클로로메탄(100 ml)과 물(50 ml)의 혼합용매에 분산시킨 다음 탄산나트륨 수용액으로 반응용액의 pH를 pH 8.0 내지 9.0로 조절하였다. 이 후, 유기층을 분리하고 감압 농축하여 N-(4-[2-(2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸]벤조일)-L-글루탐산 디에틸 에스테르(91.48% HPLC 순도)(7.38g)을 수득하였다.In a flask, 4- (2- [2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoic acid (10.0 g) and dimethyl Formamide (70 ml) was added and stirred for 20 minutes, followed by addition of N-methylmorpholine (10.3 g). The mixture was cooled to 5 ° C. and 2-chloro-4,6-dimethoxy-1,3,5-triazine (7.53 g) was added. After the reaction was stirred at 5 ° C. for 1 hour, L-glutamic acid diethyl ester hydrochloride (10.3 g) was added thereto, and the temperature was raised to 25 ° C. After about 1 hour, the reaction was completed by TLC. Water (186 ml) and dichloromethane (186 ml) were added to the reaction mixture, which was stirred for 15 minutes and allowed to stand. The layers were separated and the organic layer was concentrated under reduced pressure and replaced with anhydrous ethanol (340 ml). The reaction solution was heated to 75 ° C., and p-toluene sulfonic acid (16.8 g) dissolved in anhydrous ethanol (290 ml) was slowly added dropwise to the reaction mixture for 1 hour. The resulting slurry was refluxed for 1 hour, then cooled to 25 ° C. and filtered. Washed with anhydrous ethanol (134 ml) to give pemetrexed diethyl ester p-toluene sulfonate. The solid (10.0 g) thus obtained was dispersed in a mixed solvent of ethanol (100 ml), dichloromethane (100 ml) and water (50 ml), and then the pH of the reaction solution was adjusted to pH 8.0 to 9.0 with an aqueous sodium carbonate solution. Thereafter, the organic layer was separated and concentrated under reduced pressure to obtain N- (4- [2- (2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidine-5- Il) ethyl] benzoyl) -L-glutamic acid diethyl ester (91.48% HPLC purity) (7.38 g) was obtained.

<실시예 1> 고 순도의 N-(4-[2-(2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸]벤조일)-L-글루탐산 디에틸 에스테르(페메트렉세드 디에틸 에스테르)의 제조Example 1 N- (4- [2- (2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) of high purity Preparation of ethyl] benzoyl) -L-glutamic acid diethyl ester (pemetrexed diethyl ester)

제조예에서 얻은 저순도를 가지는 N-(4-[2-(2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸]벤조일)-L-글루탐산 디에틸 에스테르(91.48% HPLC 순도)(7.38g)에 디메틸설폭시드(12 ml)와 에탄올(40ml)을 플라스크에 채우고 50℃로 가열한 후, 완전히 용해될 때까지 교반하였다. 그 다음 아세톤(24 ml)을 약 10분 동안 적가하고, 얻어진 현탁액을 1시간 동안 22~25℃로 냉각시켰다. 30분 동안 22~25℃에서 교반한 후, 현탁액을 여과하고 고체를 이소프로판올(10ml)로 세정하였다. 습윤 고체를 50℃에서 5시간 동안 건조하여 미백색 고체 6.13g(수율 83.1%)을 99.18% 순도로 얻었다.N- (4- [2- (2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) having low purity obtained in Preparation Example Ethyl] benzoyl) -L-glutamic acid diethyl ester (91.48% HPLC purity) (7.38 g) was charged to the flask with dimethylsulfoxide (12 ml) and ethanol (40 ml) and heated to 50 ° C. until completely dissolved. Stirred. Acetone (24 ml) was then added dropwise for about 10 minutes and the resulting suspension was cooled to 22-25 ° C. for 1 hour. After stirring at 22-25 ° C. for 30 minutes, the suspension is filtered and the solid is washed with isopropanol (10 ml). The wet solid was dried at 50 ° C. for 5 hours to give 6.13 g (yield 83.1%) of an off-white solid in 99.18% purity.

1H NMR (300 MHz, DMSO) δ 1.70(m, 6H), 1.93-2.14(m, 2H), 2.43(t, 2H), 2.85(t, 2H), 2.98(t, 2H), 4.06(m, 4H), 4.42(m, 1H), 5.99(bs, 2H), 6.29(s, 1H), 7.27(d, 2H), 7.76(d, 2H), 8.61(d, 1H), 10.12(bs, 1H), 10.58(bs, 1H) 1 H NMR (300 MHz, DMSO) δ 1.70 (m, 6H), 1.93-2.14 (m, 2H), 2.43 (t, 2H), 2.85 (t, 2H), 2.98 (t, 2H), 4.06 (m , 4H), 4.42 (m, 1H), 5.99 (bs, 2H), 6.29 (s, 1H), 7.27 (d, 2H), 7.76 (d, 2H), 8.61 (d, 1H), 10.12 (bs, 1H), 10.58 (bs, 1H)

<실시예 2> N-(4-[2-(2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸]벤조일)-L-글루탐산(페메트렉세드)의 제조Example 2 N- (4- [2- (2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoyl Preparation of) -L-Glutamic Acid (Pemetlexed)

플라스크에 실시예 1에서 제조된 N-(4-[2-(2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸]벤조일)-L-글루탐산 디에틸 에스테르(99.18% HPLC 순도)(3.00 g)에 20.1ml의 1N 수산화나트륨 수용액에 첨가하고 완전히 고체가 용해될 때까지 교반시켰다. 에탄올(20.1 ml)와 물(20.1 ml)의 혼합용액을 2.5시간에 걸쳐 첨가하고, 묽은 염산을 첨가하여 pH를 3.0 내지 3.5로 조정하였다. 생성된 슬러리를 1시간 동안 65℃에서 가열한 후 실온으로 냉각하였다. 이 후 고체를 여과하고 건조하여 2.60g(98.1%)의 표제 화합물을 얻었다.N- (4- [2- (2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) prepared in Example 1 in a flask Ethyl] benzoyl) -L-glutamic acid diethyl ester (99.18% HPLC purity) (3.00 g) was added to 20.1 ml of 1N aqueous sodium hydroxide solution and stirred until complete solid dissolution. A mixed solution of ethanol (20.1 ml) and water (20.1 ml) was added over 2.5 hours, and diluted hydrochloric acid was added to adjust the pH to 3.0 to 3.5. The resulting slurry was heated at 65 ° C. for 1 hour and then cooled to room temperature. The solid was then filtered and dried to yield 2.60 g (98.1%) of the title compound.

1H NMR (300 MHz, DMSO) δ 1.95-2.10(m, 2H), 2.35(t, 2H), 2.84(t, 2H), 2.97(t, 2H), 4.36(m, 1H), 5.98(bs, 2H), 6.29(s, 1H), 7.26(d, 2H), 7.76(d, 2H), 8.49(d, 1H), 10.11(bs, 1H), 10.57(bs, 1H) 1 H NMR (300 MHz, DMSO) δ 1.95-2.10 (m, 2H), 2.35 (t, 2H), 2.84 (t, 2H), 2.97 (t, 2H), 4.36 (m, 1H), 5.98 (bs , 2H), 6.29 (s, 1H), 7.26 (d, 2H), 7.76 (d, 2H), 8.49 (d, 1H), 10.11 (bs, 1H), 10.57 (bs, 1H)

<실시예 3> N-(4-[2-(2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸]벤조일)-L-글루탐산 이나트륨 염(페메트렉세드 이나트륨염)의 제조Example 3 N- (4- [2- (2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoyl Preparation of) -L-glutamic acid disodium salt (pemetrexed disodium salt)

실시예 2로부터 얻은 N-(4-[2-(2-아미노-4,7-디히드로-4-옥소-1H-피롤로[2,3-d]피리미딘-5-일)에틸]벤조일)-L-글루탐산(2.50 g)을 2N 수산화나트륨 수용액(6.25 ml)와 물(9.5 ml)에 용해시켰다. 1N 염산을 첨가하여 혼합물의 pH를 7.5 내지 8.5로 조정하였다. 용액을 70℃에서 가열하고, 무수 에탄올(100 ml), 메탄올(10 ml)와 에틸 아세테이트(2.5 ml) 혼합 용매를 첨가하였다. 용액을 실온으로 천천히 냉각되도록 두었다. 슬러리를 여과하고, 무수 에탄올과 물의 혼합물(4:1 v/v)로 세정하였다. 생성된 백색 고체를 16시간 동안 진공 하에서 건조시켜 표제 화합물2.68g(수율: 88.7%)을 99.83% 순도로 얻었다.N- (4- [2- (2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoyl obtained from Example 2 ) -L-glutamic acid (2.50 g) was dissolved in 2N aqueous sodium hydroxide solution (6.25 ml) and water (9.5 ml). 1N hydrochloric acid was added to adjust the pH of the mixture to 7.5-8.5. The solution was heated at 70 ° C. and anhydrous ethanol (100 ml), methanol (10 ml) and ethyl acetate (2.5 ml) mixed solvent were added. The solution was allowed to cool slowly to room temperature. The slurry was filtered and washed with a mixture of anhydrous ethanol and water (4: 1 v / v). The resulting white solid was dried under vacuum for 16 hours to give 2.68 g (yield: 88.7%) of the title compound in 99.83% purity.

1H NMR (300 MHz, D2O) δ 2.02(m, 1H), 2.14(m, 1H), 2.30(t, 2H), 2.89(s, 4H), 4.27(m, 1H), 6.34(s, 1H), 7.18(d, 2H), 7.61(d, 2H) 1 H NMR (300 MHz, D 2 O) δ 2.02 (m, 1H), 2.14 (m, 1H), 2.30 (t, 2H), 2.89 (s, 4H), 4.27 (m, 1H), 6.34 (s , 1H), 7.18 (d, 2H), 7.61 (d, 2H)

Claims (10)

1) 순도가 95% 이하인 저순도 페메트렉세드 디에틸 에스테르를 디메틸포름아미드 및 디메틸설폭시드 중에서 선택된 1종 용매와 C1-4의 알코올 중에서 선택된 1종의 공용매와의 혼합용매 중에 용해시켜 용액을 제조하는 제1단계;
2) 상기 제1단계에서 제조된 용액에 반용매로 C3-C6 케톤을 첨가하여 결정을 석출시키는 제2단계; 및
3) 상기 제2단계에서 제조된 결정을 여과, 세척, 건조시켜 순도가 98.5% 이상인 고순도 페메트렉세드 디에틸 에스테르 제조방법.
1) Purity is 95% or less A first step of dissolving the low purity pemetrexed diethyl ester in a mixed solvent of one solvent selected from dimethylformamide and dimethyl sulfoxide and one cosolvent selected from alcohols of C1-4;
2) a second step of precipitating crystals by adding C3-C6 ketone as an antisolvent to the solution prepared in the first step; And
3) A method for preparing high purity pemetrexed diethyl ester having a purity of 98.5% or more by filtering, washing and drying the crystals prepared in the second step.
제1항에 있어서, 제1단계의 혼합용매가 디메틸포름아미드 또는 디메틸설폭시드 중 1종과 에탄올의 혼합용매인 고순도 페메트렉세드 디에틸 에스테르 제조방법.The method for producing high purity pemetrexed diethyl ester according to claim 1, wherein the mixed solvent of the first step is a mixed solvent of dimethylformamide or dimethyl sulfoxide with ethanol. 제2항에 있어서, 디메틸포름아미드 또는 디메틸설폭시드 중 1종과 에탄올의 혼합비가 3:10 부피비인 고순도 페메트렉세드 디에틸 에스테르 제조방법.The method for producing high purity pemetrexed diethyl ester according to claim 2, wherein the mixing ratio of one of dimethylformamide or dimethyl sulfoxide to ethanol is 3:10 by volume. 제1항에 있어서, 제2단계의 반용매가 아세톤인 고순도 페메트렉세드 디에틸 에스테르 제조방법.The method of claim 1, wherein the antisolvent of the second step is acetone. 제4항에 있어서, 반용매와 제1단계의 공용매의 혼합비가 3:5 부피비인 고순도 페메트렉세드 디에틸 에스테르 제조방법.The method for preparing high purity pemetrexed diethyl ester according to claim 4, wherein the mixing ratio of the antisolvent and the co-solvent of the first step is 3: 5 by volume. 제1항에 있어서, 제3단계의 세척이 C1-C4 알코올 중에서 선택된 1종으로 수행되는 것인 고순도 페메트렉세드 디에틸 에스테르 제조방법.The method of claim 1, wherein the washing in the third step is performed with one selected from C1-C4 alcohols. 제6항에 있어서, 제3단계의 세척이 이소프로판올로 수행되는 것인 고순도 페메트렉세드 디에틸 에스테르 제조방법.The method of claim 6, wherein the third step of washing is performed with isopropanol. 1) 제1항 내지 제7항 중 어느 한 항의 제조방법으로 고순도 페메트렉세드 디에틸 에스테르를 제조하는 제1단계;
2) 상기 제1단계에서 제조된 페메트렉세드 디에틸 에스테르와 NaOCH3, NaOCH 2CH3, KOCH3, KOCH2CH3, LiOH, NaOH, KOH, RbOH, CsOH, Ca(OH)2, SrOH 및 Ba(OH)2 중에서 선택된 하나의 염기를 반응시킨 후 용액에 산을 첨가하여 반응용액의 pH를 2.5 내지 4.0으로 조정하여 페메트렉세드를 제조하는 제2단계; 및
3) 상기 제2단계에서 제조한 페메트렉세드를 수산화나트륨 또는 탄산나트륨과 반응시키고, 산을 첨가하여 pH 7.5 내지 8.5로 조정하여 페메트렉세드 이나트륨염을 제조하는 방법.
1) a first step of producing a high-purity pemetrexed diethyl ester by the method of any one of claims 1 to 7;
2) the pemetrexed diethyl ester prepared in step 1 and NaOCH 3 , NaOCH 2 CH 3 , KOCH 3 , KOCH 2 CH 3 , LiOH, NaOH, KOH, RbOH, CsOH, Ca (OH) 2 , SrOH and One selected from Ba (OH) 2 A second step of preparing pemetrexed by reacting a base and adding an acid to the solution to adjust the pH of the reaction solution to 2.5 to 4.0; And
3) A method for preparing pemetrexed disodium salt by reacting the pemetrexed prepared in the second step with sodium hydroxide or sodium carbonate and adjusting the pH to 7.5 to 8.5 by adding an acid.
삭제delete 제8항에 있어서, 제2단계 또는 제3단계의 산이 염산, 황산 및 질산 중에서 선택된 것인 페메트렉세드 이나트륨염 제조방법.
9. The process for preparing pemetrexed disodium salt according to claim 8, wherein the acid of the second or third step is selected from hydrochloric acid, sulfuric acid and nitric acid.
KR1020110006082A 2011-01-20 2011-01-20 Preparation method of Pemetrexed diethyl ester with high purity and the preparation method of pemetrexed disodium salt comprising the thereof KR101308767B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020110006082A KR101308767B1 (en) 2011-01-20 2011-01-20 Preparation method of Pemetrexed diethyl ester with high purity and the preparation method of pemetrexed disodium salt comprising the thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020110006082A KR101308767B1 (en) 2011-01-20 2011-01-20 Preparation method of Pemetrexed diethyl ester with high purity and the preparation method of pemetrexed disodium salt comprising the thereof

Publications (2)

Publication Number Publication Date
KR20130027597A KR20130027597A (en) 2013-03-18
KR101308767B1 true KR101308767B1 (en) 2013-12-31

Family

ID=48178403

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020110006082A KR101308767B1 (en) 2011-01-20 2011-01-20 Preparation method of Pemetrexed diethyl ester with high purity and the preparation method of pemetrexed disodium salt comprising the thereof

Country Status (1)

Country Link
KR (1) KR101308767B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101578093B1 (en) * 2013-09-05 2015-12-16 주식회사 삼양바이오팜 Improved method for preparing an intermediate for preparing pemetrexed with high purity and method for preparing pemetrexed with high purity by using the intermediate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416211A (en) 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
WO2001014379A2 (en) 1999-08-23 2001-03-01 Eli Lilly And Company A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
US20010011142A1 (en) 1997-09-26 2001-08-02 Kjell Douglas Patton Processes and intermediates useful to make antifolates
WO2008021405A1 (en) 2006-08-14 2008-02-21 Sicor Inc. Crystalline forms of pemetrexed diacid and processes for the preparation thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416211A (en) 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
US20010011142A1 (en) 1997-09-26 2001-08-02 Kjell Douglas Patton Processes and intermediates useful to make antifolates
WO2001014379A2 (en) 1999-08-23 2001-03-01 Eli Lilly And Company A novel crystalline form of disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic acid salt and processes therefor
WO2008021405A1 (en) 2006-08-14 2008-02-21 Sicor Inc. Crystalline forms of pemetrexed diacid and processes for the preparation thereof

Also Published As

Publication number Publication date
KR20130027597A (en) 2013-03-18

Similar Documents

Publication Publication Date Title
RU2581585C2 (en) Method of producing 4-{4-[({[4-chloro-3-(trifluoromethyl) phenyl] amino} -carbonyl) amino]-3-fluorophenoxy}-n-methylpyridine-2-carboxamide, salts and monohydrate thereof
US20190135806A1 (en) Solid state forms of venetoclax and processes for preparation of venetoclax
EP2794610B1 (en) Processes and intermediates for preparing pralatrexate
KR20080040695A (en) Preparation of a 7h-pyrrolo[2,3-d]pyrimidine derivative
CA2827455C (en) Process for the production of a pemetrexed salt
KR101578093B1 (en) Improved method for preparing an intermediate for preparing pemetrexed with high purity and method for preparing pemetrexed with high purity by using the intermediate
JP2017534637A (en) Preparation method of revaprazan hydrochloride
KR101308767B1 (en) Preparation method of Pemetrexed diethyl ester with high purity and the preparation method of pemetrexed disodium salt comprising the thereof
RU2556209C2 (en) New method for producing antifolate agents having glutamic acid fragment in its structure
TWI617562B (en) An improved process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine from 4-amino-2,5-dimethoxypyrimidine
SG182576A1 (en) Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide
CA2722818C (en) Preparation of 1,7´-dimethyl-2´-propyl-2,5´-bi-1h-benzimidazole
AU2010313521B2 (en) Methods of preparing 1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone
KR20180105450A (en) A Method of preparing Fimarsartan choline salt and hydrate thereof
JP6336166B2 (en) Novel intermediate of imidafenacin, method for producing the same, and method for producing imidafenacin using the same
CN108341771B (en) Preparation method of 3-cyano-2, 6-dihydroxypyridine sodium hydrate
KR101152607B1 (en) Process for preparing 6-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-3-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine
KR100512870B1 (en) Method for producing 7α-methoxycephalosporin derivative sodium salt 7-hydrate
KR101156497B1 (en) Method for production of aminoimidazole derivative
KR100841041B1 (en) Process for preparation of bamifylline hydrochloride

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160823

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20170905

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20180904

Year of fee payment: 6